Pharma Business, A Game of Profits

  • News
  • July 12, 2017

New Delhi : Despite the efforts and rules of Indian government to make medical facilities affordable for the end users, there seems no benefits to the consumers. Like govt made compulsory to write generic medicines for the doctors, so that patients can get same composition but at lower prices.

In actual, the situation is totally different; doctors stopped prescribing pocket-friendly medicines. There were times when with lymphan at cost of 50 Paise per tablet treated diarrhoea with 3 doses but today,  for even a small health issues doctor prescribed you at least Rs.150 of the medicines.

This is all the game of commissions like expensive medicine means more profits. Government all policies seem to fail here as no one can restrict doctors to write affordable medicines. Drug manufacturers give more commission to the doctors on prescribing expensive medicines. It means that the more expensive the medicines, the more expensive the commission.

Doctors, now become businessman they don’t care about the pocket of the patients but only think about their profits. Common man is all time survivor for all the changes.

Now, this is the time to see how government will ensure medical facilities at lower prices for the consumers. Things are not that much simple as they seems to be, now there needs a strong policy to make doctors write best possible affordable generic prescription to the patients

  • Related Posts

    13 Years after Oxytocin Order, HC Seeks Compilance Status

    GWALIOR: The Gwalior Bench of the Madhya Pradesh High Court has directed the state government to submit a comprehensive compliance status report. This order addresses the implementation of the court’s…

    Centre Pushes Haryana to Fast-Track AIIMS Rewari

    New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nearly Three in Ten Products in Indian Local Markets Perceived as Counterfeit; Pharmaceuticals and FMCG among Worst-Affected Sectors: ASPA–CRISIL Intelligence Report

    Nearly Three in Ten Products in Indian Local Markets Perceived as Counterfeit; Pharmaceuticals and FMCG among Worst-Affected Sectors: ASPA–CRISIL Intelligence Report

    Culture reports reveal bacteria damaged cornea of five patients from Kuchaman

    Culture reports reveal bacteria damaged cornea of five patients from Kuchaman

    FSSAI prohibits Dabur from selling food products with ‘100%’ claims

    FSSAI prohibits Dabur from selling food products with ‘100%’ claims

    ORSL reinforces its commitment to improve diarrhoeal prevention in children

    ORSL reinforces its commitment to improve diarrhoeal prevention in children

    ‘Donors got mixer grinders, cash’: blood banks in Bengal under scanner over ‘illegal’ sale to other States

    ‘Donors got mixer grinders, cash’: blood banks in Bengal under scanner over ‘illegal’ sale to other States

    CREATE Medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license pact with Monash University

    CREATE Medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license pact with Monash University